BioSpace News Archive

Genetown

Mevion Introduces New MEVION S250-FIT Proton Therapy System

This new compact system can fit in existing LINAC vaults, making proton therapy more accessible and affordable than ever before.

October 21, 2022
·
4 min read
Pharm Country

U.S. Food and Drug Administration (FDA) Accepts Supplemental New Drug Application for CAMZYOS® (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy to Reduce the Need for Septal Reduction Therapy

U.S. Food and Drug Administration (FDA) Accepts Supplemental New Drug Application for CAMZYOS ® (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy to Reduce the Need for Septal Reduction Therapy.

October 21, 2022
·
16 min read
Lone Star Bio

Lantern Pharma to Present at the ThinkEquity Conference on Wednesday, October 26 at 1:00 p.m. ET

Lantern Pharma Inc. today announced that Lantern management will be presenting at the ThinkEquity Conference, which is being held on October 26th , 2022 in New York, NY.

October 21, 2022
·
4 min read
Drug Development

CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research

CinCor Pharma, Inc. (NASDAQ: CINC) today announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.

October 21, 2022
·
5 min read
South Rampart Pharma Announces Presentation at Arrowhead’s 16th Annual Pain Therapeutics Summit

South Rampart Pharma (“South Rampart” or the “Company”) today announced that Hernan Bazan, MD, FACS, CEO and Co-Founder of South Rampart Pharma and the Endowed John Ochsner Professor of Cardiovascular Innovation at the Ochsner Clinic, will present at Arrowhead’s 16th Annual Pain Therapeutics Summit.

October 21, 2022
·
2 min read
Drug Development

Anokion Announces Presentation of Data from Phase 1 ACeD Clinical Trial Evaluating KAN-101 as a Treatment for Celiac Disease at the 19th International Celiac Disease Symposium

Anokion Announces Presentation of Data from Phase 1 ACeD Clinical Trial Evaluating KAN-101 as a Treatment for Celiac Disease at the 19th International Celiac Disease Symposium.

October 21, 2022
·
3 min read
Genetown

Akebia Therapeutics Announces Poster Presentation at ASN Kidney Week 2022

Akebia Therapeutics, Inc. today announced that it will present data at the American Society of Nephrology Kidney Week 2022 ( ASN Kidney Week 2022 ), which will take place in Orlando, November 3-6, 2022.

October 21, 2022
·
1 min read
Biotech Bay

Aligos Therapeutics to Present Nonclinical and Clinical Data for its Chronic Hepatitis B and NASH Portfolio at AASLD’s The Liver Meeting® 2022

Aligos Therapeutics, Inc. today announced seven upcoming poster presentations at The Liver Meeting® (November 4-8, 2022), hosted by the American Association for the Study of Liver Diseases (AASLD).

October 21, 2022
·
8 min read
Biotech Bay

Asher Bio to Present First Preclinical Data for AB359, its CD8-targeted IL-2 Immunotherapy for Hepatitis B at AASLD 2022

Asher Biotherapeutics, Inc. today announced that it will present the first preclinical data for AB359.

October 21, 2022
·
2 min read
Pharm Country

Almirall PROSES study demonstrates appropriate acne treatment decreases the burden of impact on acne sufferers’ social and emotional wellbeing

Almirall, LLC, a global biopharmaceutical company focused on skin health, is excited to announce the release of its privately funded PROSES study at this year’s Fall Clinical Dermatology Conference® in Las Vegas, Nevada, October 20-23, 2022.

October 21, 2022
·
10 min read